Dale N. Gerding, MD, a world-renowned researcher of C. difficile and other infectious diseases, has received the Veterans Health Administration’s highest research honor, the 2013 William S. Middleton Award.
Gerding is a research physician at Edward Hines Jr. VA Hospital and a professor in the Department of Medicine of Loyola University Chicago Stritch School of Medicine.
The William S. Middleton Award for outstanding achievement in biomedical or behavioral research is the highest honor for scientific achievement awarded by the VA’s Biomedical Laboratory Research and Development Service.
The award recognizes Gerding’s exemplary record of involvement in, and service to, the VA and the biomedical profession. It also recognizes Gerding’s seminal contributions to the epidemiology, pathogenesis, diagnosis and treatment of hospital infections, with a primary focus on C. difficile. His work has had a broad impact on the clinical care of veterans and of the general population. Gerding will receive $50,000 per year for three years in research support.
Gerding’s research interests include the epidemiology and prevention of C. difficile, antimicrobial resistance and antimicrobial distribution. He is the author of more than 350 peer-reviewed journal articles, book chapters and reviews. He holds patents for the use of non-toxigenic C. difficile for the prevention and treatment of this disease. This was shown in 2013 to significantly reduce relapse of C. difficile infection in a phase II patient clinical trial.
Source: Loyola University Medical Center